[Prenatal therapy with magnesium sulphate and intestinal obstruction due to meconium in preterm newborns].
Terapia prenatal con sulfato de magnesio y obstrucción intestinal por meconio en recién nacidos pretérmino.
Heart failure
Insuficiencia cardiaca
Insuficiencia respiratoria
Magnesium sulfate
Meconium obstruction
Obstrucción meconial
Preterm infant
Recién nacido prematuro
Respiratory insufficiency
Sulfato de magnesio
Journal
Anales de pediatria
ISSN: 2341-2879
Titre abrégé: An Pediatr (Engl Ed)
Pays: Spain
ID NLM: 101765626
Informations de publication
Date de publication:
23 Dec 2020
23 Dec 2020
Historique:
received:
09
07
2020
revised:
29
10
2020
accepted:
31
10
2020
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
29
12
2020
Statut:
aheadofprint
Résumé
Magnesium sulphate (MgSO An analytical retrospective study was conducted on < 32 weeks preterm babies admitted to a tertiary-level hospital (January 2016-December 2017). Epidemiological, prenatal and postnatal data on the outcomes were obtained, analysed and compared in both groups (exposed to MgSO The study included 201 patients (146 exposed and 55 non-exposed). There were no significant differences in the mean gestational age (28.4 ± 2.2 vs. 28.7 ± 2.8 weeks, respectively), or in the rest of epidemiological and perinatal variables. Prenatal corticosteroid therapy was more frequent in the MgSO This study found no correlations between MgSO4 therapy and meconium obstruction or cardiorespiratory failure.
Identifiants
pubmed: 33358528
pii: S1695-4033(20)30483-5
doi: 10.1016/j.anpedi.2020.10.022
pii:
doi:
Types de publication
English Abstract
Journal Article
Langues
spa
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020. Publicado por Elsevier España, S.L.U.